SANCTURA
Pronunciation: TROES-pee-um


What it isQuaternary muscarinic antagonist; overactive bladder.
Why this oneIts charge keeps it out of the CNS, so it is the antimuscarinic of choice where cognition matters.
What limits itPeripheral anticholinergic effects remain. Take on an empty stomach; food halves absorption, and it is renally cleared.
Animated chart of estimated U.S. prescriptions per year, Overactive bladder meds (1970–2026). Trospium enters in 2004 (estimated).
Principal riskAnticholinergic burden, though poor CNS penetration
Legacy pregnancy categoryC
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Overactive bladder (urge incontinence, urgency, frequency) | Adults | 20 mg BID | 20 mg BID | 20 mg BID |
Renal Severe renal impairment (CrCl <30 mL/min): 20 mg once daily at bedtime.
Hepatic Undefined (not studied).
Available strengths
Pregnancy Undefined.
Lactation Undefined.
| Strength | #/mo | generic $/mo | CostPlus | |
|---|---|---|---|---|
| 20 mg | tab | 60 BID | $12.69 | offered |
Available combined with: xanomeline / trospium
Generic entry2010
Open Trospium in the interactive console ↗

Open Trospium in the interactive console ↗